The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 02, 2018

Filed:

Nov. 13, 2013
Applicant:

Codiak Biosciences, Inc., Woburn, MA (US);

Inventors:

Jan Lötvall, Mölnlycke, SE;

Jonas Andrej Nilsson, Kållered, SE;

Assignee:

Codiak BioSciences, Inc., Cambridge, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 48/00 (2006.01); C12N 15/113 (2010.01); C12N 15/11 (2006.01); C12N 15/85 (2006.01);
U.S. Cl.
CPC ...
C12N 15/1135 (2013.01); C12N 15/111 (2013.01); C12N 15/85 (2013.01); C12N 2310/14 (2013.01); C12N 2320/30 (2013.01); C12N 2320/32 (2013.01);
Abstract

A method of producing nanovesicles comprising an oligonucleotide inhibitor to an oncogene or a proto-oncogene or the gene product thereof, said method comprises a) introducing a DNA sequence encoding an oligonucleotide capable of inhibiting a human oncogenic or proto-oncogenic transcription factor, into a mammalian cell; b) allowing the cell to express said inhibitor oligonucleotide; and c) obtaining nanovesicles containing said inhibitor oligonucleotide from said cell. Nanovesicles produced by the claimed method can be effectively and specifically targeted to e.g. cancer cells to deliver the inhibitor oligonucleotide.


Find Patent Forward Citations

Loading…